Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Advances in Experimental Medicine and Biology
|
January 1, 1992
Modulation of Ca2+ release and Na+ channel function in skeletal muscle by fatty acids
J E Fletcher, S J Wieland, J Beech, et al.
Anesthesiology
|
July 1, 1987
Malignant hyperthermia susceptibility in neuroleptic malignant syndrome
S N Caroff, H Rosenberg, J E Fletcher, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
August 5, 2021
Factors associated with Noninvasive ventilation compliance in patients with ALS/MND
C E Jackson, T D Heiman-Patterson, M Sherman, et al.
Journal of Neurochemistry
|
March 29, 2000
Elevated cortical extracellular fluid glutamate in transgenic mice expressing human mutant (G93A) Cu/Zn superoxide dismutase
G M Alexander, J S Deitch, J L Seeburger, et al.
Pediatric Neurology
|
November 1, 1986
Malignant hyperthermia susceptibility in X-linked muscle dystrophies
T D Heiman-Patterson, H M Natter, H R Rosenberg, et al.
Seminars in Arthritis and Rheumatism
|
June 1, 1990
Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndrome
J Varga, T D Heiman-Patterson, D L Emery, et al.
Muscle & Nerve
|
October 27, 1997
Biochemical and genetic studies in a family with mitochondrial myopathy
T D Heiman-Patterson, Z Argov, J M Chavin, et al.
Electromyography and Clinical Neurophysiology
|
December 1, 1991
Clinical and electrophysiological assessments in ALS patients
A J Tahmoush, J A Gillespie, J F Hulihan, et al.
Neurology
|
June 1, 1991
Factors influencing outcome of prednisone dose reduction in myasthenia gravis
M A Miano, T M Bosley, T D Heiman-Patterson, et al.
The American Journal of Medicine
|
August 1, 1984
Neuroleptic malignant syndrome. Patient with unique clinical and physiologic features
G P Downey, M Rosenberg, S Caroff, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Advances in Experimental Medicine and Biology
|
January 1, 1992
Modulation of Ca2+ release and Na+ channel function in skeletal muscle by fatty acids
J E Fletcher, S J Wieland, J Beech, et al.
Anesthesiology
|
July 1, 1987
Malignant hyperthermia susceptibility in neuroleptic malignant syndrome
S N Caroff, H Rosenberg, J E Fletcher, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
August 5, 2021
Factors associated with Noninvasive ventilation compliance in patients with ALS/MND
C E Jackson, T D Heiman-Patterson, M Sherman, et al.
Journal of Neurochemistry
|
March 29, 2000
Elevated cortical extracellular fluid glutamate in transgenic mice expressing human mutant (G93A) Cu/Zn superoxide dismutase
G M Alexander, J S Deitch, J L Seeburger, et al.
Pediatric Neurology
|
November 1, 1986
Malignant hyperthermia susceptibility in X-linked muscle dystrophies
T D Heiman-Patterson, H M Natter, H R Rosenberg, et al.
Seminars in Arthritis and Rheumatism
|
June 1, 1990
Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndrome
J Varga, T D Heiman-Patterson, D L Emery, et al.
Muscle & Nerve
|
October 27, 1997
Biochemical and genetic studies in a family with mitochondrial myopathy
T D Heiman-Patterson, Z Argov, J M Chavin, et al.
Electromyography and Clinical Neurophysiology
|
December 1, 1991
Clinical and electrophysiological assessments in ALS patients
A J Tahmoush, J A Gillespie, J F Hulihan, et al.
Neurology
|
June 1, 1991
Factors influencing outcome of prednisone dose reduction in myasthenia gravis
M A Miano, T M Bosley, T D Heiman-Patterson, et al.
The American Journal of Medicine
|
August 1, 1984
Neuroleptic malignant syndrome. Patient with unique clinical and physiologic features
G P Downey, M Rosenberg, S Caroff, et al.
Page
of 3